• Date:Tue, Apr 29, 2014
  • Time:12:00 PM EDT
  • Duration:1 hour
  • Host(s):PHA Classroom

Presenter Information

Michael McGoon, MD

Michael McGoon, MD, is Professor of Medicine and Consultant in Cardiovascular Diseases at Mayo Clinic, Rochester, Minnesota. Dr. McGoon attended medical school and completed internship at Johns Hopkins before transferring to Mayo for residency and cardiology training. Dr. McGoon served as Director of the PH Center at Mayo since he initiated it in 1996 until 2007. He is board certified in Internal Medicine and Cardiology. For over 25 years, he has led multiple clinical trials of PH medications, starting with intravenous prostacyclin.  He recently served as chair of the Steering Committee of the REVEAL registry. Dr. McGoon has been a member of PHA’s Scientific Leadership Council since 1994, serving as Chair from 2002 to 2004 and as a Distinguished Advisor since 2004. He was Chair of the Board of Trustees of PHA (2006-2008), and currently chairs the Pulmonary Hypertension Care Centers Oversight Committee.

PH Treatments: What's on the Horizon

Please register for this meeting.

Meeting Description:

With the recent FDA approval of three new treatments in just a few months, the past year has brought exciting advances in PH research! Join Dr. Michael McGoon of the Mayo Clinic for a presentation on the current treatments available for PH, as well as new treatments in the pipeline.

Register for this Meeting:

* Required Field